The Ohio State University and Battelle have partnered to launch an independent state-of-the art neurotechnology accelerator focused on treatments for patients with neurological disorders.

For years Carter Caldwell had adamantly rejected doctors’ recommendations that he consider surgery to treat the frequent, uncontrolled seizures that were ravaging his brain.

Ohio State and Battelle, a science and technology not-for-profit organization, have partnered to help launch the NeuroTech Institute to develop new treatments for patients with neurological disorders.